This positive correlation may indicate the critical role of UBE2C as a tumour oncogene during the cell cycle through enhancing the G1/S and G2/M transitions that prevent cancer apoptosis and promotes tumour cell proliferation via controlling the PI3K/AKT/mTOR signalling pathway [41]. This evidence concerns the gene MTOR and cancer.